DK3063278T3 - PREPARATION OF VIRAL VECTORS - Google Patents

PREPARATION OF VIRAL VECTORS Download PDF

Info

Publication number
DK3063278T3
DK3063278T3 DK14858802.3T DK14858802T DK3063278T3 DK 3063278 T3 DK3063278 T3 DK 3063278T3 DK 14858802 T DK14858802 T DK 14858802T DK 3063278 T3 DK3063278 T3 DK 3063278T3
Authority
DK
Denmark
Prior art keywords
cell
virus
cells
cho
sequence
Prior art date
Application number
DK14858802.3T
Other languages
Danish (da)
English (en)
Inventor
Paul Michael Howley
Liang Liu
Original Assignee
Sementis Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2013904242A external-priority patent/AU2013904242A0/en
Application filed by Sementis Ltd filed Critical Sementis Ltd
Application granted granted Critical
Publication of DK3063278T3 publication Critical patent/DK3063278T3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/24011Poxviridae
    • C12N2710/24111Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/24011Poxviridae
    • C12N2710/24111Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24141Use of virus, viral particle or viral elements as a vector
    • C12N2710/24143Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/24011Poxviridae
    • C12N2710/24111Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24151Methods of production or purification of viral material
    • C12N2710/24152Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK14858802.3T 2013-11-01 2014-11-03 PREPARATION OF VIRAL VECTORS DK3063278T3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2013904242A AU2013904242A0 (en) 2013-11-01 Viral vector manufacture
AU2014900370A AU2014900370A0 (en) 2014-02-07 Orthopox vectors and propagation
PCT/AU2014/050330 WO2015061858A1 (en) 2013-11-01 2014-11-03 Viral vector manufacture

Publications (1)

Publication Number Publication Date
DK3063278T3 true DK3063278T3 (en) 2018-06-06

Family

ID=53003022

Family Applications (2)

Application Number Title Priority Date Filing Date
DK14858802.3T DK3063278T3 (en) 2013-11-01 2014-11-03 PREPARATION OF VIRAL VECTORS
DK18154084.0T DK3375882T3 (da) 2013-11-01 2014-11-03 Fremstilling af viral vektor

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK18154084.0T DK3375882T3 (da) 2013-11-01 2014-11-03 Fremstilling af viral vektor

Country Status (24)

Country Link
US (2) US10544397B2 (cg-RX-API-DMAC7.html)
EP (2) EP3375882B1 (cg-RX-API-DMAC7.html)
JP (2) JP6682443B2 (cg-RX-API-DMAC7.html)
KR (1) KR102047030B1 (cg-RX-API-DMAC7.html)
CN (1) CN106255758B (cg-RX-API-DMAC7.html)
AU (1) AU2014344738B2 (cg-RX-API-DMAC7.html)
CA (1) CA2931518C (cg-RX-API-DMAC7.html)
CY (1) CY1121414T1 (cg-RX-API-DMAC7.html)
DK (2) DK3063278T3 (cg-RX-API-DMAC7.html)
ES (1) ES2670034T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20180789T1 (cg-RX-API-DMAC7.html)
HU (1) HUE037718T2 (cg-RX-API-DMAC7.html)
LT (1) LT3063278T (cg-RX-API-DMAC7.html)
NO (1) NO3063278T3 (cg-RX-API-DMAC7.html)
NZ (1) NZ720241A (cg-RX-API-DMAC7.html)
PL (1) PL3063278T3 (cg-RX-API-DMAC7.html)
PT (1) PT3063278T (cg-RX-API-DMAC7.html)
RS (1) RS57290B1 (cg-RX-API-DMAC7.html)
RU (1) RU2658487C2 (cg-RX-API-DMAC7.html)
SG (1) SG11201603919XA (cg-RX-API-DMAC7.html)
SI (1) SI3063278T1 (cg-RX-API-DMAC7.html)
SM (1) SMT201800267T1 (cg-RX-API-DMAC7.html)
TR (1) TR201807128T4 (cg-RX-API-DMAC7.html)
WO (1) WO2015061858A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2019001919A (es) * 2016-08-19 2019-09-04 Sementis Ltd Vacunas virales.
JP2018081568A (ja) * 2016-11-17 2018-05-24 グローリー株式会社 紙幣収納装置および紙幣処理機
CN119403822A (zh) * 2022-06-30 2025-02-07 巴法里安诺迪克有限公司 用于生产改良安卡拉痘苗病毒(mva)的哺乳动物细胞系
WO2024064608A2 (en) * 2022-09-20 2024-03-28 Intergalactic Therapeutics, Inc. Best1 vectors and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2604183B1 (fr) 1986-09-23 1988-12-30 Transgene Sa Sequence d'adn, vecteurs, virus recombinants et procede mettant en oeuvre des virus de la vaccine recombinants capables de se multiplier dans les cellules cho
DE69534289T2 (de) * 1994-04-29 2006-04-27 Baxter Healthcare S.A. Rekombinante Pockenviren mit fremden Polynukleotiden in wichtigen Regionen
ATE504653T1 (de) * 2002-08-07 2011-04-15 Bavarian Nordic As Vaccinia virus wirtspektrum gene zur erhöhung des titers von avipoxviren
FR2884255B1 (fr) * 2005-04-11 2010-11-05 Vivalis Utilisation de lignees de cellules souches aviaires ebx pour la production de vaccin contre la grippe
CN101541972A (zh) * 2006-08-04 2009-09-23 都柏林城市大学 生产重组生物产品的方法

Also Published As

Publication number Publication date
NZ720241A (en) 2019-10-25
SMT201800267T1 (it) 2018-07-17
AU2014344738A1 (en) 2016-06-09
NO3063278T3 (cg-RX-API-DMAC7.html) 2018-07-28
CA2931518A1 (en) 2015-05-07
CY1121414T1 (el) 2020-05-29
EP3063278B1 (en) 2018-02-28
CN106255758A (zh) 2016-12-21
CA2931518C (en) 2021-03-09
HRP20180789T1 (hr) 2018-09-07
KR102047030B1 (ko) 2019-11-20
RU2016121425A (ru) 2017-12-04
EP3063278A1 (en) 2016-09-07
DK3375882T3 (da) 2019-12-16
RU2658487C2 (ru) 2018-06-21
HUE037718T2 (hu) 2018-09-28
WO2015061858A1 (en) 2015-05-07
PT3063278T (pt) 2018-05-25
SG11201603919XA (en) 2016-07-28
EP3375882A1 (en) 2018-09-19
RS57290B1 (sr) 2018-08-31
PL3063278T3 (pl) 2018-08-31
HK1223395A1 (en) 2017-07-28
KR20160079868A (ko) 2016-07-06
JP2016534755A (ja) 2016-11-10
EP3063278A4 (en) 2017-04-12
US20200190482A1 (en) 2020-06-18
SI3063278T1 (sl) 2019-04-30
ES2670034T3 (es) 2018-05-29
JP2020039340A (ja) 2020-03-19
AU2014344738B2 (en) 2019-03-21
CN106255758B (zh) 2020-06-23
EP3375882B1 (en) 2019-10-16
TR201807128T4 (tr) 2018-06-21
JP6682443B2 (ja) 2020-04-15
US10544397B2 (en) 2020-01-28
LT3063278T (lt) 2018-07-10
US20170029784A1 (en) 2017-02-02

Similar Documents

Publication Publication Date Title
CN111593073B (zh) 双报告基因骨架载体、四质粒假病毒包装系统、包装新冠肺炎假病毒
US20250179524A1 (en) Recombinant poxviruses for cancer immunotherapy
CN110055224B (zh) 一种基因修饰的免疫细胞及其制备方法和应用
JP7721589B2 (ja) 細胞の遺伝子修飾のための非組込みdnaベクター
AU2019271972B2 (en) Adenovirus polynucleotides and polypeptides
CN113831394B (zh) 一种非洲猪瘟病毒asfv基因的重组病毒组合及由其制备的疫苗
KR20210091740A (ko) 세포-매개된 종양용해 바이러스 요법용 향상된 시스템
KR20170048396A (ko) 재조합 변형된 백시니아 바이러스 앙카라 (mva) 필로바이러스 백신
DK3063278T3 (en) PREPARATION OF VIRAL VECTORS
AU2017313450B2 (en) Viral vaccines
CN116323955A (zh) 通过crispr/cas介导的体内末端解析拯救重组腺病毒
KR20230112625A (ko) 나이세리아 고노레아에 대한 백신접종을 위한 조성물 및 방법
HK1260426B (en) Viral vector manufacture
HK1260426A1 (en) Viral vector manufacture
HK1223395B (en) Viral vector manufacture
CN117999090A (zh) 鼠痘病毒用于癌症免疫治疗和疫苗的用途